Login / Signup

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.

Ranju BaralAnn LevinChris OderoClint PecenkaCollins TabuEvans MwendoGeorge BonsuJohn BawaJohn Frederick DadzieJoyce CharoKwadwo Odei Antwi-AgyeiKwame Amponsa-AchianouRose Eddah JalangoRouden MkisiScott GordonTemwa MzengezaWinthrop MorganFarzana Muhib
Published in: PloS one (2021)
Cost estimates in this analysis are meant to inform country decision-makers as they face the question of whether to continue malaria vaccination, should the intervention receive a positive recommendation for broader use. Additionally, important cost drivers for vaccine delivery are highlighted, some of which might be influenced by global and country-specific financing and existing procurement mechanisms. This analysis also adds to the evidence available on vaccine delivery costs for products delivered outside the standard immunization schedule.
Keyphrases
  • plasmodium falciparum
  • randomized controlled trial
  • healthcare
  • primary care
  • clinical trial
  • study protocol